Tag: Roche refocusing strategy
Sanders and Novo Nordisk CEO clash, Roche shifts focus, and more in Pharmalittle
Bernie Sanders, the U.S. Senate health committee chair, has taken a stand against major pharmacy benefit managers in an effort to lower the prices of Novo Nordisk's popular diabetes and obesity treatments, Ozempic and...